Pfizer R&D Chief Mikael Dolsten Reflects On The COVID-19 Pandemic Experience

For Pfizer Inc. President-Worldwide R&D Mikael Dolsten, the experience of overseeing the development of the COVID-19 vaccine Comirnaty, in partnership with BioNTech SE, and the antiviral Paxlovid have been unlike any other experience in his 13-year career leading the R&D team at the big pharma.

Dolsten sat down with Scrip at the Galien Foundation's Prix Galien USA Forum in New York on 26 October and reflected on the experience and the remaining challenges and